Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0182167 SILICONE-BASED COMPOSITION FOR SKIN TREATMENT
The present embodiments may relate to topically delivered compounded medications for the treatment of scar tissue, skin disorders, and/or other ailments. In...
2017/0182165 THERMAL ACCELERANT COMPOSITIONS AND METHODS OF USE
A thermal accelerant is delivered to a tissue site and localized to modulate the shape, extent or other characteristic of RF or microwave-induced hyperthermic...
2017/0182164 METHOD FOR TREATING CANCER
The present invention relates to a method for the treatment of cancer in a subject which comprises the steps of: (i) administering electroporation to a tumour...
2017/0182163 MULTI-SPECIFIC ANTIBODIES FOR CROSS-NEUTRALIZATION OF MULTIPLE FILOVIRUS GLYCOPROTEINS
Methods for treating and for preventing Filovirus infections are disclosed, as well as compositions therefor.
2017/0182162 LIQUID PHARMACEUTICAL COMPOSITION
The present invention relates to novel liquid pharmaceutical compositions of adalimumab, which include adalimumab or a biosimilar thereof, a citrate buffering...
2017/0182161 Antigen Binding Proteins that Bind PD-L1
There is disclosed compositions and methods relating to or derived from anti-PD-L1 antibodies. More specifically, there is disclosed fully human antibodies...
2017/0182160 METHODS OF TREATING ATOPIC DERMATITIS WITH IL-31 MONOCLONAL ANTIBODIES
Novel compositions derived from antigen-binding sites of immunoglobulins having affinity for IL-31 are provided. The compositions exhibit immunological binding...
2017/0182159 ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-6
The invention relates to antibody molecules having specificity for antigenic determinants of IL-6, therapeutic uses of the antibody molecules and methods for...
2017/0182158 QSOX1 AS AN ANTI-NEOPLASTIC DRUG TARGET
The present invention provides methods for tumor treatment by administering an inhibitor of quiescin sulfhydryl oxidase 1 (QSOX1), compositions comprising such...
2017/0182157 IMMUNOSTIMULATOR AND METHOD FOR PRODUCING THE SAME
Disclosed is an immunostimulator containing virus-like particles, in which the virus-like particles contain an outer coat protein containing an amino acid...
2017/0182156 METHODS FOR ENHANCING THE EFFICACY OF A TUMOR-DIRECTED IMMUNE RESPONSE
As described below, the present invention features methods for enhancing the efficacy of a tumor antigen in inducing an anti-cancer immune response in a...
2017/0182155 SYNTHETIC GLUCOPYRANOSYL LIPID ADJUVANTS
Compounds, particularly, glucopyranosyl lipid adjuvant (GLA) compounds, having the following structure (I) are provided: ##STR00001## or a pharmaceutically...
2017/0182153 YEAST-BASED COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF HEPATITIS DELTA VIRUS INFECTION
Disclosed are immunotherapeutic compositions and methods for preventing and/or treating hepatitis delta virus (HDV) infection, including yeast-based HDV...
2017/0182152 NON-TOXIC ADJUVANT FORMULATION COMPRISING A MONOPHOSPHORYL LIPID A (MPLA)-CONTAINING LIPOSOME COMPOSITION AND A...
Provided herein is an adjuvant formulation comprising a monophosphoryl lipid A (MPLA)-containing liposome composition to saponin (e.g., QS-21), wherein the...
2017/0182151 RSV F Protein Mutants
The present disclosure relates to RSV F protein mutants, nucleic acids or vectors encoding a RSV F protein mutant, compositions comprising a RSV F protein...
2017/0182150 VACCINATION WITH mRNA-CODED ANTIGENS
The present invention relates to vaccines comprising at least one mRNA encoding at least one antigen for use in the treatment of a disease in an elderly...
2017/0182149 Composite Antigenic Sequences and Vaccines
The invention relates to composite antigens comprising a peptide with contiguous amino acid sequence derived from a plurality of antigenic epitopes of one or...
2017/0182148 IMMUNOPOTENTIATOR-LINKED OLIGOMERIC INFLUENZA IMMUNOGENIC COMPOSITIONS
Disclosed herein are immunogenic compositions for preventing infection with influenza viruses wherein the immunogenic compositions comprises an immunogen such...
2017/0182147 CD40 LIGAND FUSION PROTEIN VACCINE
Provided are methods of generating an immune response to any of various antigens including foreign antigens such as infectious agent antigens. In general, the...
2017/0182146 POLYPEPTIDES AND IMMUNIZING COMPOSITIONS CONTAINING GRAM POSITIVE POLYPEPTIDES AND METHODS OF USE
The present invention provides isolated polypeptides isolatable from a Staphylococcus spp. Also provided by the present invention are compositions that include...
2017/0182145 METHODS AND COMPOSITIONS FOR SUPPRESSING VIRULENCE OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS
The present invention is directed to methods of suppressing the virulence of one or more virulence antigenic factors of methicillin resistant Staphylococcus...
2017/0182144 ANTI-MYCOPLASMA SPP. SUBUNIT VACCINE
Provided in the present invention are anti-Mycoplasma spp. subunit vaccines, especially proteins suitable for being used as the active ingredient of the...
2017/0182143 ANTI-MYCOPLASMA SPP. SUBUNIT VACCINE
Provided in the present invention are anti-Mycoplasma spp. subunit vaccines, especially proteins suitable for being used as the active ingredient of the...
2017/0182142 ANTI-MYCOPLASMA SPP. SUBUNIT VACCINE
Provided in the present invention are anti-Mycoplasma spp. subunit vaccines, especially proteins suitable for being used as the active ingredient of the...
2017/0182141 M Hyo Multivalent Vaccine and Uses Thereof
The present invention relates to compositions or vaccines for combating Mycoplasma hyopneumoniae (M hyo), Porcine Circovirus type 2 (PCV2), and Porcine...
2017/0182140 INDUCED ACTIVATION IN DENDRITIC CELLS
The present invention is directed to a composition and method which to treat diseases and to enhance a regulated immune response. More particularly, the...
2017/0182139 CANCER THERAPY
Provided herein is technology relating to cancer treatment and prevention and particularly, but not exclusively, to compositions and methods related to...
2017/0182138 IN SITU ANTIGEN-GENERATING CANCER VACCINE
The invention provides compositions and methods for utilizing scaffolds in cancer vaccines.
2017/0182137 BREAST AND OVARIAN CANCER VACCINES
The compositions described herein include an epitope of a peptide that may elicit an immune response in a subject following administration. The compositions...
2017/0182136 COMPOSITIONS AND METHODS OF ENHANCING IMMUNE RESPONSES TO EIMERIA OR LIMITING EIMERIA INFECTION
Vaccine, vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality...
2017/0182135 DRY POWDER FIBRIN SEALANT
The invention provides a composition comprising a mixture of first microparticles that comprise fibrinogen and trehalose, and second microparticles that...
2017/0182134 Delivery of Therapeutic Compounds to the Brain and Other Tissues
The present invention relates to the intrathecal (IT) administration of recombinant enzyme to treat lysosomal storage disorders. In an exemplary embodiment,...
2017/0182133 COMPOSITIONS FOR PROVIDING AGENTS THAT DEGRADE IN WATER
Compositions and methods for mucosal delivery of agents are provided. The compositions are intended for administration to mucosal surface, such as oral,...
2017/0182132 USE OF NUTRITIONAL COMPOSITIONS INCLUDING LACTOFERRIN IN SUPPORTING RESISTANCE TO DISEASES AND CONDITIONS
The present disclosure relates to the use of nutritional compositions including lactoferrin produced by a non-human source in supporting resistance to diseases...
2017/0182131 INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5
A composition in the form of an injectable aqueous solution, the pH of which is between 6.0 and 8.0, includes at least a basal insulin, the isoelectric point...
2017/0182130 METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS
The present disclosure provides a method of treating diseases or disorders associated with CFTR protein dysfunction, including Cystic Fibrosis, by...
2017/0182129 SYSTEMIC DELIVERY OF VIRUS VECTORS ENCODING UROCORTIN-2 AND RELATED GENES TO TREAT DIABETES-RELATED CARDIAC...
In alternative embodiments, provided are methods for treating, ameliorating or protecting (preventing) congestive heart failure (CHF) or a diabetes-related...
2017/0182128 METHOD OF TREATING HEART FAILURE
The present invention includes methods, systems, uses, and means for the delivery of one or more anti-fibrotic agents into the pericardial space for the...
2017/0182127 METHOD AND COMPOSITION FOR TREATING HEART FAILURE WITH PRESERVED EJECTION FRACTION
A pharmaceutical composition for treatment of persons afflicted of heart failure with preserved ejection fraction (HFPEF), diastolic heart failure (DHF) or...
2017/0182126 METHOD FOR PREVENTION OR TREATMENT OF INTRACTABLE INFLAMMATORY BOWEL DISEASE
An object of the present invention is to provide methods for preventing or treating a steroid-resistant or steroid-dependent inflammatory bowel disease. The...
2017/0182125 COMPOSITIONS FOR PROMOTING THE HEALING OF WOUNDS
The present invention provides compositions comprising granulocyte-macrophage colony-stimulating factor (GM-CSF), sucrose octasulfate or sucralfate and...
2017/0182124 FGF21 Derivatives and Uses Thereof
The invention relates to a derivative of a FGF21 protein having a cysteine residue at a position corresponding to position 167, 169, 170, 171, 172, 173, 174,...
2017/0182123 METHODS AND USES FOR MODULATING BILE ACID HOMEOSTASIS AND TREATMENT OF BILE ACID DISORDERS AND DISEASES
Provided herein are methods of modulating bile acid homeostasis or treating a bile-acid related or associated disorder, comprising using variants and fusions...
2017/0182122 METHODS AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISORDERS AND DISEASES
Provided herein are variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of FGF19...
2017/0182121 CHARGED LIPOPROTEIN COMPLEXES AND THEIR USES
The present disclosure provides charged lipoprotein complexes that include as one component a negatively charged phospholipid that is expected to impart the...
2017/0182120 METHOD OF TREATING OR PREVENTING POLYCYSTIC KIDNEY DISEASE AND PKD ANIMAL MODEL WITH EXOGENOUS NEUTROPHIL...
Disclosed is a method of treating or preventing polycystic kidney disease (PKD) by administration of neutrophil geleatinase-associated lipocalin (Ngal)...
2017/0182118 PREPARATIONS CONTAINING AMORPHOUS EMODEPSIDE
The invention relates to preparations comprising amorphous emodepside in a polyvinylpyrrolidone matrix, pharmaceuticals comprising such preparations, and their...
2017/0182117 THERAPEUTIC COMPOSITIONS INCLUDING THERAPEUTICSMALL MOLECULES AND USES THEREOF
Disclosed herein are methods and compositions for the treatment and/or prevention of diseases or conditions comprising administration of TSM, and/or naturally...
2017/0182116 SMAC Mimetic
A SMAC mimetic and pharmaceutical compositions thereof and methods of use.
2017/0182115 PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER
The present invention relates to a combination comprising a substance with inhibiting effect on the ileal bile acid transport system (I BAT) and at least one...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.